Search Results 1031-1040 of 17125 for monoclonal antibody

1. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; An anthracycline containing chemotherapy regimen. Intent to ...

2. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

   Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

3. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

   Receipt of any marketed or investigational biologic products (monoclonal or polyclonal antibody) ... This also applies to patients who previously participated in ...

4. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

   Participants with an allergy/ intolerance to a monoclonal antibody or biologic, or any of the excipients of the investigational product. Monoclonal antibodies ...

5. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Monoclonal antibodies =< 3 half-lives prior to registration; Radiation therapy. Last fraction of craniospinal irradiation or total body irradiation =< 3 ...

6. International Group Publishes Updated Criteria for Diagnosing Multiple Myeloma

   Rajkumar said multiple myeloma is always preceded sequentially by two asymptomatic conditions, monoclonal gammopathy of undetermined significance (MGUS) and ...

7. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

   small molecules and >30 mL/min for monoclonal antibodies unless otherwise specified in the Arm Specific Eligibility. These cut-off values may be modified ...

8. Immune globulin-slra (intravenous route) - Side effects & uses - Mayo Clinic

   Description. Immune globulin-slra injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

9. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   - Chemotherapy, immunotherapy, hormonal therapy and monoclonal antibodies (but excluding nitrosurea, mitomycin-C, targeted therapy, and radiation) ≤ 28 ...

10. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dL; > 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; Serum immunoglobulin free light chain ≥ 10 mg ...